19 July 2019 - BEAM Alliance

BEAM Alliance: Time to give your feedback on how to characterize antimicrobial activity!

The BEAM Alliance proposed a six-way approach to characterize ATM activity, with the aim of opening new doors in the…

12 April 2019 - BEAM Alliance

BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

By linking a specific ATM to a specific step of the infectious process, novel clinical outcomes could be identified that…

25 March 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PUSH Incentives: ‘Supporting financial investments on R&D to de-risk antimicrobial development!’

The intention of this Memo is to provide different suggestions to help ensure that the R&D funding instruments (e.g. from…

BEAM News
Member News
Events

Latest news of BEAM Alliance

19 July 2019 - BEAM Alliance

BEAM Alliance: Time to give your feedback on how to characterize antimicrobial activity!

The BEAM Alliance proposed a six-way approach to characterize ATM activity, with the aim of opening new doors in the…

06 June 2019 - BEAM Alliance

Emergency on planet AMR: a vital pipeline to protect

The sooner we come up with practical solutions, the more SMEs (and currently developed products) we can save from vanishing.…

12 April 2019 - BEAM Alliance

BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

By linking a specific ATM to a specific step of the infectious process, novel clinical outcomes could be identified that…

25 March 2019 - BEAM Alliance

BEAM Alliance is releasing a new position paper on PUSH Incentives: ‘Supporting financial investments on R&D to de-risk antimicrobial development!’

The intention of this Memo is to provide different suggestions to help ensure that the R&D funding instruments (e.g. from…

24 September 2018 - BEAM Alliance

Antibiorésistance : BEAM Alliance tire la sonnette d’alarme

Priorités : Alerter les pouvoirs publics sur le besoin médical et l’urgence associés à la pénurie de nouveaux traitements contre…

07 June 2018 - BEAM Alliance

BEAM writes to Representatives of the US congress to support The Pandemic and All Hazards Preparedeness Act (PAHPA) currently discussed at the House of Representatives.

BEAM writes to Representatives of the US congress to support The Pandemic and All Hazards Preparedeness Act (PAHPA) currently discussed…

page 1/3

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

17 July 2019 - Polyphor Ltd

Polyphor closes the Phase III PRISM studies of murepavadin intravenous formulation and evaluates further product improvement options

“We would like to thank the patients, the investigators and all the scientists involved for their contribution to the development…

16 July 2019 - Pherecydes Pharma

Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections

“This project will be an important step forward for phage therapy and a new hope for patients,” commented Guy-Charles Fanneau…

15 July 2019 - Motif Bio plc

Motif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim

Graham Lumsden, Chief Executive Officer, said: “As we take this next step towards potential regulatory approval for iclaprim in the…

03 July 2019 - Da Volterra

Da Volterra Announces Completion of Patient Recruitment for its Phase 2 Clinical Study with DAV132, a Novel Microbiota Protective Therapy

“We are pleased to announce the completion of recruitment for our first-in-patient Phase 2 study for our innovative and most…

03 July 2019 - Nosopharm

Nosopharm and Evotec enter into collaboration to accelerate development of novel antibiotics

NOSO-502 is the first clinical candidate in the novel antibiotic class called Odilhorhabdins (ODLs). It inhibits the bacterial ribosome with…

27 June 2019 - PhagoMed Biopharma GmbH

Investors Support Phage Therapy; Novel Approach to Solve The Antibiotics Crisis Receives Further Millions

PhagoMed Biopharma GmbH (PhagoMed) works on solutions for the global antibiotics crisis – the increasing rate of multi-drug resistances against…

page 1/15

Events

09 July 2019

REVIVE webinar: Infection models for antimicrobial R&D: Intracellular models

In this webinar, Françoise van Bambeke, Research Director Cellular and Molecular Pharmacology, Louvain Drug Research Institute, Catholic University of Louvain…

11 June 2019

REVIVE webinar: Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research

In this webinar, William J. Weiss, Director, PreClinical Services, University of North Texas System College of Pharmacy, will introduce experimental…

05 June 2019

Advancing Data Technologies to corner Antimicrobial Resistance

Antimicrobial resistance (AMR) already now is the largest global threat to Health and Food Safety (source: WHO). Without the focused…

03 June 2019

BIO International Convention

The key benefits of attending the 2019 BIO International Convention are access to global biotech and pharma leaders via BIO…

03 June 2019

6th World Congress and Exhibition on Antibiotics and Antibiotic Resistance

Theme: Challenges and New Concepts in Antibiotics Research

23 May 2019

Global Scale-up Program: Venture Scaling Strategy & Preparation

Venture assessment and individual intake Scale-up Entrepreneurial Finance Scale-up Entrepreneurial Marketing & Global Strategy

22 May 2019

NAPD Symposium ‘Accelerating antibiotic development in Europe’

The Netherlands Antibiotic Development Platform (NADP) is organizing its second annual meeting, titled 'Accelerating antibiotic development in Europe'. The program…

21 May 2019

GARDP webinar: Mining Chemical Libraries for New Antibacterials

Despite the promise of target-based drug discovery ushered in by the genomics era, no mechanistically novel rationally designed antibiotic has…

13 April 2019

29th ECCMID

ESCMID's yearly congress attracts nearly 13'000 participants. ECCMID offers a wide range of sessions including: keynotes, symposia, poster sessions, educational…

page 2/3